ACCP guidelines classification scheme: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
m (Bot: Adding CME Category::Cardiology) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The '''Grading scheme''' is used to indicate whether a therapy is recommended or not according to the balance among benefits, risks, burdens, and possibly cost, and the degree of confidence in estimates of benefits, risks, and burdens.<ref name="pmid16424429">{{cite journal |author=Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B | The '''Grading scheme''' is used to indicate whether a therapy is recommended or not according to the balance among benefits, risks, burdens, and possibly cost, and the degree of confidence in estimates of benefits, risks, and burdens.<ref name="pmid16424429">{{cite journal| author=Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al.| title=Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. | journal=Chest | year= 2006 | volume= 129 | issue= 1 | pages= 174-81 | pmid=16424429 | doi=10.1378/chest.129.1.174 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16424429 }} </ref> | ||
===Grading Scheme Classification=== | ===Grading Scheme Classification=== | ||
| Line 10: | Line 10: | ||
===Level of Evidence=== | ===Level of Evidence=== | ||
The level of evidence is classified according to the factors that include the study design, the consistency of the results, and the directness of the evidence.<ref name="pmid16424429">{{cite journal |author=Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B | The level of evidence is classified according to the factors that include the study design, the consistency of the results, and the directness of the evidence.<ref name="pmid16424429">{{cite journal| author=Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al.| title=Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. | journal=Chest | year= 2006 | volume= 129 | issue= 1 | pages= 174-81 | pmid=16424429 | doi=10.1378/chest.129.1.174 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16424429 }} </ref> | ||
*'''Grade A:''' High | *'''Grade A:''' High | ||
| Line 17: | Line 17: | ||
==Resources== | ==Resources== | ||
[http://www.chestnet.org/accp/guidelines/grading-strength-recommendations-and-quality-evidence-clinical-guidelines Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines]<ref name="pmid16424429">{{cite journal |author=Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B | [http://www.chestnet.org/accp/guidelines/grading-strength-recommendations-and-quality-evidence-clinical-guidelines Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines]<ref name="pmid16424429">{{cite journal| author=Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B et al.| title=Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. | journal=Chest | year= 2006 | volume= 129 | issue= 1 | pages= 174-81 | pmid=16424429 | doi=10.1378/chest.129.1.174 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16424429 }} </ref> | ||
==References== | ==References== | ||
| Line 25: | Line 25: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
Latest revision as of 19:08, 14 March 2016
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
The Grading scheme is used to indicate whether a therapy is recommended or not according to the balance among benefits, risks, burdens, and possibly cost, and the degree of confidence in estimates of benefits, risks, and burdens.[1]
Grading Scheme Classification
- Grade 1: Strong recommendation
- Grade 2: Weak recommendation
Level of Evidence
The level of evidence is classified according to the factors that include the study design, the consistency of the results, and the directness of the evidence.[1]
- Grade A: High
- Grade B: Moderate
- Grade C: Low
Resources
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines[1]
References
- ↑ 1.0 1.1 1.2 Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B; et al. (2006). "Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force". Chest. 129 (1): 174–81. doi:10.1378/chest.129.1.174. PMID 16424429.